October 2007

Karus scientist presents at key industry conferences

(DOC 32KB)

October 2007

Novel synthetic analogues of the natural product histone deacetylase inhibitor FK228

(PDF 91KB)

October 2006

Drummond Paris named as Chairman of Karus Therapeutics

(PDF 86KB)

May 2006

Karus Therapeutics appoints Simon Kerry as CEO

(PDF 60KB)

December 2005

Collaboration with Sareum Holdings

(PDF 73KB)

July 2005

Cancer and heart disease drug discovery company is latest spin-out from the University of Southampton

(PDF 56KB)

Yurek-George, et al

The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor; J Med Chem; 2007

(PDF 126KB)

Yurek-George, et al

Total synthesis of Spiruchostatin A, a potent histone deacetylase inhibitor; J Am Chem Soc; 2004

(PDF 64KB)

Davidson, et al

The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells…; Chem Biochem; 2005

(PDF 238KB)